The main technology of Nanjing Finechem Holdings Co., Ltd for producing reliable and high-purity pharmaceutical and agrochemical intermediates has been patented. We focus on the precise organic synthesis of Cloxacillin and can strictly modify its molecular structure and impurity spectrum to meet the standards of the pharmacopoeia. Chiral resolution and purification of Quinidine to ensure high enantiomeric purity are crucial for the efficacy of cardiovascular drugs. Amitraz's selective catalytic method maximizes output while minimizing negative environmental impacts. Our technology strikes a balance among production efficiency, regulatory compliance and system sustainability through continuous research and development and process optimization.
